HeartBeam Locks In $300K Severance and Full Equity Acceleration for Outgoing CEO
BEAT is trading near its 52-week low of $0.481 (3.8% above the low).
Summary
HeartBeam disclosed the executed separation agreement for former CEO Robert Eno, including $300,000 severance, full vesting acceleration of all equity awards, and an extended option exercise period to December 2027.
Key Events · Executive and Board Changes · BEAT
-
CEO Severance Finalized
Under the separation agreement executed July 30, 2026, former CEO Robert Eno will receive a $300,000 lump sum cash payment, equivalent to nine months of base salary.
-
Full Equity Acceleration
All outstanding stock options and restricted stock units held by Eno will fully vest and become immediately exercisable upon the agreement's effective date, increasing potential dilution.
-
Extended Option Exercise Window
The post-termination exercise period for Eno's stock options is extended to the earlier of December 31, 2027 or the option's original expiration, potentially creating a multi-year overhang.
-
Advisory Role Retained
Eno will serve as a non-employee advisor through December 31, 2026 for a one-time $1,000 retainer, maintaining a formal tie to the company during the transition.
Analysis · BEAT · Industrial Applications And Services
The amended filing for the June 24 CEO departure now includes the executed separation terms: a $300,000 cash severance, full acceleration of all outstanding stock options and RSUs, and an option exercise window extended through December 2027. For a company trading near its 52-week low and carrying a going concern warning, the equity acceleration and cash payout represent a material cost and potential dilution, while the extended exercise period could create overhang. The terms also include a nominal $1,000 advisory retainer, keeping the former CEO engaged as a consultant through year-end.
At the time of this filing, BEAT was trading at $0.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $27.7M. The 52-week trading range was $0.48 to $4.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.